InvestorsHub Logo
Followers 45
Posts 5645
Boards Moderated 0
Alias Born 04/05/2015

Re: antihama post# 285509

Thursday, 05/28/2020 7:33:45 AM

Thursday, May 28, 2020 7:33:45 AM

Post# of 701930
Think this guy did previous with a negative slant.
So now he is hedging his bets a bit.
But he still perpetuates the fallacy that the trial was 'halted' for 2yrs:-

To further complicate the matter, in 2015, the Food and Drug Administration halted DCVax-L's clinical trial.


And he gives this baloney:-

Even with a potential survival head start compared to other clinical trials due to a screening criterion requiring patients to be progression-free before enrollment, patients' survival in the two cohorts of DCVax-L's clinical trial compares very favorably to historical rates.


What is he talking about? All these ndGBM trials require subjects to be progression free at the time of enrolment.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News